Register Login

NEURONETICS, INC. (STIM)

SymbolSTIM
NameNEURONETICS, INC.
SectorHEALTH CARE
RegionNorth America
IndustryMedical/Dental Instruments
Address3222 PHOENIXVILLE PIKE, MALVERN, Pennsylvania, 19355, United States
Telephone+1 610 640-4202
Fax—
Email—
Websitehttps://www.neurostar.com
IncorporationUNDEFINED
Incorporated On—
Employees—
Fiscal Year—
Public Since—
ExchangesNASDAQ
Auditor—
Audit StatusNOT PROVIDED
Reporting Status—
CIK0001227636
Description

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.

Additional info from NASDAQ:
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.

2026-07-06 12:30

Neuronetics to Participate in a Panel Discussion at B. Riley Securities Mind, Muscle & Vision Summit on July 16, 2026

Read more
2026-06-23 20:38

(99% Neutral) NEURONETICS, INC. (STIM) Announces New Board Appointment

Read more
2026-06-17 20:57

Amin Avinash 🔴 sold 42.5K shares of Neuronetics, Inc. (STIM) Transaction Date: Jun 15, 2026 | Filing ID: 274343

Read more
2026-06-17 20:47

Madryn Asset Management, LP 🟢 acquired 72.5K shares of Neuronetics, Inc. (STIM) Transaction Date: May 28, 2026 | Filing ID: 274303

Read more
2026-06-08 20:38

📋 Sullivan Keith J (Ex-Officer and Director) plans to sell 42K shares of Neuronetics, Inc. (at $1.29 each, total $54K) Filed: Jun 08, 2026 | ID: 004449

Read more
2026-06-02 20:30

Neuronetics Appoints Robert Greene as Senior Vice President Sales

Read more
2026-06-02 12:32

Neuronetics Highlights Continued Advancements in TMS Research at CTMSS 2026

Read more
2026-05-29 21:10

Rosengarten Megan 🟢 acquired 30.0K shares of Neuronetics, Inc. (STIM) Transaction Date: May 28, 2026 | Filing ID: 000003

Read more
2026-05-29 21:05

MUIR GLENN P 🟢 acquired 30.0K shares of Neuronetics, Inc. (STIM) Transaction Date: May 28, 2026 | Filing ID: 000002

Read more
2026-05-29 21:04

Cucuz Sasha 🟢 acquired 30.0K shares of Neuronetics, Inc. (STIM) Transaction Date: May 28, 2026 | Filing ID: 000002

Read more